A fresh look at proton pump inhibitor (PPI)-associated adverse events through a CYP2C19 pharmacogenetic lens.
Expert Opin Drug Metab Toxicol
; 19(2): 53-56, 2023 02.
Article
in En
| MEDLINE
| ID: mdl-36919492
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pharmacogenetics
/
Proton Pump Inhibitors
Type of study:
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Expert Opin Drug Metab Toxicol
Journal subject:
METABOLISMO
/
TOXICOLOGIA
Year:
2023
Document type:
Article
Affiliation country:
United States